Checkerspot

Oakland, United States Founded: 2016 • Age: 10 yrs
High-performance materials are developed using synthetic biology for diverse applications.

About Checkerspot

Checkerspot is a Healthcare company based in Oakland (United States) founded in 2016 by Scott Franklin. It operates as a high-performance materials are developed using synthetic biology for diverse applications. It operates in the Healthcare and Chemicals & Materials sectors. Checkerspot has raised $144.03 million across 7 funding rounds from investors including United States Department of Agriculture, Plug and Play Tech Center and DIC Global. Its chief executive is John Krzywicki. Checkerspot offers products and services including Culinary Oil. Its focus areas include Life Sciences, Genomics, Applied Genomics and Synthetic Biology. Its legal entity is Checkerspot, Inc. Its competitors include Amyris, GSK, Inscripta, Avidity Biosciences and Pivot Bio and 4 more; 7 of its 9 listed competitors have raised funding.

Company details

Checkerspot was founded in 2016 and is headquartered in Oakland, United States, within the biotechnology sector. Advanced biotechnology and chemistry are employed to produce novel materials suited for industrial, medical, and consumer sectors. Genome engineering and synthetic biology techniques are utilized to generate new compounds, which are subsequently processed into materials exhibiting targeted properties for various end uses.

  • Headquarters Oakland, United States
  • Founders Scott Franklin
  • Sectors
    Healthcare
    Chemicals & Materials
  • Website checkerspot.com
  • Social LinkedIn X Instagram
  • Legal Name Checkerspot, Inc.
Key Metrics

Products & Services of Checkerspot

Checkerspot offers a comprehensive portfolio of products and services, including Culinary Oil.

Culinary Oil
Food Product

Premium oil made from fermented algae for enhanced taste and stability.

Funding Insights of Checkerspot

Checkerspot has successfully raised a total of $144.03M across 7 strategic funding rounds. The most recent funding activity was a Series D round of $27.43 million completed in July 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $144.03M
  • Total Rounds 7
  • Last Round Series D β€” $27.43M
  • First Round $100,000

    (Jul 2017)

  • Investors Count 13

All 7 funding rounds of Checkerspot with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2026$27.43MSeries D––
–
Nov 2025$7.6MSeries C––
–
Sep 2022$55MSeries C–ArrowMark Partners
May 2020$36MSeries B–Viking Global Investors
Apr 2019$13MSeries A–Builders VC
Jun 2018$5MSeed–KdT Ventures
Jul 2017$100,000Grant––
Valuation history

13 investors in total: 13 institutional.

Investors in Checkerspot

Checkerspot has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include United States Department of Agriculture, Plug and Play Tech Center and DIC Global.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Investments are made in technologies that modernize industries like agriculture and construction.
–builders.vc-
Early-stage investments in science-driven companies are made.
–breakout.vc-
Private investment firm focused on multiple sectors
–vikingglobal.comGreenwich, United States
Early-stage investments are made in frontier science ventures.
–kdtvc.comBlack Mountain, United States
Startups are accelerated and invested in across multiple tech sectors.
2006plugandplaytechcenter.comSunnyvale, United States
Investments in multiple sectors are made by Sahsen Ventures.
–sahsen.comSeattle, United States
-
–godfreycapital.tcc.mode-
Seed and early-stage investments are made across US and India.
–refactor.comBurlingame, United States
Venture capital is provided by Cavallo Ventures in multiple sectors.
–cavallovc.comSan Francisco, United States
Diversified asset management services are provided to investors.
2007arrowmarkpartners.comDenver, United States
Premium access

Investor details for Checkerspot

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Checkerspot

8 people are tracked at Checkerspot (3 in leadership, 5 in board & advisors).

NameRoleGroup
Scott Franklin
Co-Founder & CSOLeadership
John Krzywicki
CEOLeadership
Charles Dimmler
Co-Founder & CEOLeadership
Cain McClary
Board MemberBoard & advisors
David Greenwood
Board MemberBoard & advisors
Walter Solomon
Board MemberBoard & advisors
Julia Moore
Board MemberBoard & advisors
Jim Kim
Board MemberBoard & advisors
Premium access

Complete people profiles for Checkerspot

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Checkerspot

3 dated milestones of Checkerspot across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Checkerspot is founded.
  2. Funding First funding round of $100K.
  3. Funding Latest funding round, Series D, of $27.4M.

Competitors of Checkerspot

Checkerspot has 9 listed competitors in our database, 7 of them funded. They include Amyris, GSK, Inscripta, Avidity Biosciences and Pivot Bio, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
amyris.com2003Emeryville, United States$487.2M747
Developer of renewable products for industrial solutions
gsk.com1715Brentford, United Kingdom–90,913
Developer of pharmaceuticals and vaccines for various therapeutic areas
inscripta.io2015Helsinki, Finland$853,384–
Speech recognition solutions are provided by Inscripta for healthcare professionals.
aviditybiosciences.com2012San Diego, United States$142.54M253
Antibody-siRNA complexes are developed for cancer treatment.
pivotbio.com2010Berkeley, United States$618.08M256
Nitrogen-fixing microbes for corn crop nutrition are developed and applied.
ginkgobioworks.com2008Boston, United States$795.75M1,218
Gene editing-based cultured ingredients are provided for agriculture.
sutrobio.com2003United States$171.85M235
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
syngenta.com2000Basel, Switzerland––
Crop protection solutions and hybrid seeds are provided for farming.
asimov.com2017Boston, United States$209.4M87
Provider of integrated suite for advanced genetic design and manufacturing
Premium access

Detailed competitors of Checkerspot

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Checkerspot

Websites that share an audience with Checkerspot (checkerspot.com).

Similar websites

Websites whose visitors overlap most with Checkerspot. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
checkerspotbrewing.com
100%
–#6,481,908View details

Top companies in Genomics & Gene Therapy Platforms

10 companies that operate in the same segment as Checkerspot (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.34 BUSD 301.49 M1,372
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M562
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Checkerspot

Premium access

Complete news archive for Checkerspot

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Checkerspot

Checkerspot was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Checkerspot is headquartered in Oakland, United States. It is registered at Oakland, California, United States.

John Krzywicki is the current CEO of Checkerspot.

Checkerspot is a funded company, having raised a total of $144.03M across 7 funding rounds to date. The company's 1st funding round was a Grant of $100K, raised on Jul 2017.

Checkerspot was founded in 2016 and is headquartered in Oakland, United States, within the biotechnology sector. Advanced biotechnology and chemistry are employed to produce novel materials suited for industrial, medical, and consumer sectors. Genome engineering and synthetic biology techniques are utilized to generate new compounds, which are subsequently processed into materials exhibiting targeted properties for various end uses.

Checkerspot's top competitors include Syngenta, Sutro Biopharma and Avidity Biosciences.

Checkerspot offers Culinary Oil.

Checkerspot operates through Checkerspot, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available